Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Oliver Sartor MD
Oliver Sartor MD Advisory Board
Jeffrey Kirshner MD, FACP, FASCO
Jeffrey J. Kirshner MD, FACP, FASCO Advisory Board
Eric Jonasch MD
Eric Jonasch MD Advisory Board
See All Experts
featured
Published in Oncology

Expert Opinion / Interview · April 15, 2015

Not Quite There: Using CTCs in Clinical Practice—Part 1

Tony Nimeh MD
Interview by
Tony Nimeh MD
Minetta Liu MD
Interview with
Minetta C Liu MD

 

 Save  Recommend
 Share

Additional Info

  1. Liu MC, Mego M, Nakamura S, et al. Clinical validity of circulating tumor cell (CTC) enumeration in 841 subjects with metastatic breast cancer. Proc Am Soc Clin Oncol. 2011; abstract 10592.

  2. Bidard F-C, Peeters DJ, Fehm T, et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. Lancet Oncol. 2014;(4):406-414.
  3. Liu MC. By the numbers: does circulating tumor cell enumeration have a role in metastatic breast cancer? J Clin Oncol. 2014; 32(31):3479-3482.
  4. Smerage JB, Barlow WE, Hortobagyi GN, et al. Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500 [published online ahead of print June 2, 2014]. J Clin Oncol. doi: 10.1200/JCO.2014.56.2561.

Further Reading

Most Read This Week

Recently Updated